Stock Information
Cytokinetics Inc (CYTK)
Ticker Symbol: CYTK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $8,158.74 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -6.5332
Revenue (TTM): $0.72 M
Dividend Yield: N/A%
ROE: -131.19%
Latest News
-
10 Health Care Stocks With Whale Alerts In Today's Session
Fri, May 1, 2026 1:35 PM
-
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates
Fri, May 1, 2026 11:45 AM
-
Why The Cytokinetics (CYTK) Story Is Shifting After Myqorzo Approvals And ACACIA Expectations
Thu, Apr 30, 2026 6:06 PM
-
Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress
Tue, Apr 28, 2026 11:30 AM
-
Cytokinetics To Showcase Nine MYQORZO Presentations At ESC Heart Failure 2026 In Barcelona
Tue, Apr 28, 2026 7:38 AM
Key Financials
Financial data not available
